Ab&B Bio-Tech Co., Ltd. JS (stock code: 02627) released its monthly return for November 2025, confirming no changes in authorized or issued share capital during the reporting period. The total authorized share capital remains RMB 393,442,600, consisting of 296,361,845 H shares and 97,080,755 domestic shares, both with a par value of RMB 1.

The issuer reported that the number of issued H shares remains 296,361,845, and the number of issued domestic shares stands at 97,080,755. No share options, warrants, convertibles, or new agreements to issue shares were disclosed, and there were no treasury shares. The announcement concluded with confirmation of compliance regarding applicable rules and regulations as required.